A bottle of anti-depressant pills named Paxil are shown in Miami, Fla.
A bottle of anti-depressant pills named Paxil are shown in Miami, Fla. - 
Listen To The Story
Marketplace

 According to the Justice Department, it's the biggest settlement in a health-care fraud case in history. GlaxoSmithKline, the huge British drug-maker, will pay $3 billion in fines and compensation to the U.S. government and the states.

That's for pushing doctors to prescribe drugs for uses that weren't approved by the FDA, and for failing to inform U.S. regulators of potential dangerous side-effects.

But off-label drug uses are really pretty common. So why is it considered so bad, apparently, that Glaxo has been encouraging off-label uses for prescription drugs?

Here to talk with us in today's Mid-day Extra is Steven Woloshin, professor of medicine at the Dartmouth Institute for Health Policy and Clinical Practice.

“I think the best compliment I can give is not to say how much your programs have taught me (a ton), but how much Marketplace has motivated me to go out and teach myself.” – Michael in Arlington, VA

As a nonprofit news organization, what matters to us is the same thing that matters to you: being a source for trustworthy, independent news that makes people smarter about business and the economy. So if Marketplace has helped you understand the economy better, make more informed financial decisions or just encouraged you to think differently, we’re asking you to give a little something back.

Become a Marketplace Investor today – in whatever amount is right for you – and keep public service journalism strong. We’re grateful for your support.

Follow David Brancaccio at @DavidBrancaccio